Growth stocks are attractive to many investors, as above-average financial growth helps these stocks easily grab the market's attention and produce exceptional returns. However, it isn't easy to find a great growth stock.
Growth stocks are attractive to many investors, as above-average financial growth helps these stocks easily grab the market's attention and produce exceptional returns. But finding a growth stock that can live up to its true potential can be a tough task.
Growth investors focus on stocks that are seeing above-average financial growth, as this feature helps these securities garner the market's attention and deliver solid returns. But finding a great growth stock is not easy at all.
Investors seek growth stocks to capitalize on above-average growth in financials that help these securities grab the market's attention and produce exceptional returns. But finding a growth stock that can live up to its true potential can be a tough task.
Growth stocks are attractive to many investors, as above-average financial growth helps these stocks easily grab the market's attention and produce exceptional returns. But finding a great growth stock is not easy at all.
Roku’s ROKU fourth-quarter 2019 results, set to be released on Feb 13, are expected to benefit from a thriving ad business.Roku’s expanded licensing partnerships and advertising revenues from The Roku Channel and advertising video on demand (AVOD) partners are expected to ha
Molina Healthcare, Inc.’s MOH fourth-quarter 2019 adjusted earnings of $2.73 per share surpassed the Zacks Consensus Estimate by 4.2% on the back of declining expenses. However, the bottom line fell 29.6% year over year, mainly due to lower revenues.Also, total revenues of $4.
Dominion Energy Inc. D reported fourth-quarter 2019 operating earnings of $1.18 per share, beating the Zacks Consensus Estimate of $1.16 by 1.7%. Operating earnings came near the midpoint of the company’s guided range of $1.10-$1.25 per share. The bottom line improved from the
United Parcel Service, Inc. UPS reached a tentative agreement with the Independent Pilot’s Association (IPA), representing its 2,959 flight crew members, for a two-year contract extension. The tentative deal approved by the five-pilot IPA Executive Board includes retirement en
Datadog, Inc DDOG is scheduled to report fourth-quarter 2019 results on Feb 13.For the quarter, the company expects revenues in the range of $101 million to $103 million.The Zacks Consensus Estimate for revenues is currently pegged at $102.2 million.The consensus mark for fourth
Martin Marietta Materials, Inc.’s MLM shares dropped 1.6% in the pre-market trading session, after it reported lower-than-expected fourth-quarter 2019 earnings.Nonetheless, the company highlighted 2019 as the most profitable year in its history. Improved shipments, pricing and
Lyft, Inc. LYFT is set to report fourth-quarter results on Feb 11, after market close. Lyft’s top line is likely to have benefited from high customer adoption. Its cheap pricing strategy is expected to have helped it gain market share over its rivals.
Tempur Sealy International, Inc. TPX is slated to report fourth-quarter 2019 results on Feb 13, before the opening bell.In the last reported quarter, the company’s adjusted earnings of $1.30 per share beat the Zacks Consensus Estimate by 15% and revenues of $821 million outpac
Omnicom OMC reported fourth-quarter 2019 earnings per share of $1.89 (on an adjusted basis) which beat the Zacks Consensus Estimate by 2 cents. Earnings increased 12 cents year over year.
Hess Corporation HES has been on a bit of a cold streak lately, but there might be light at the end of the tunnel for this overlooked stock. And for technical investors there is some hope when looking at HES given that, according to its RSI reading of 29.51, it is now in oversol
Genesco Inc. GCO has been on a bit of a cold streak lately, but there might be light at the end of the tunnel for this overlooked stock. And for technical investors there is some hope when looking at GCO given that, according to its RSI reading of 28.85, it is now in oversold te
SVB Leerink analysts have crunched the numbers, and they say that Paul Hudson, the new CEO of the French drug giant Sanofi, is right in his predictions for the company’s monoclonal antibody Dupixent.